Joana Fernandes, PhD,  —

Researchers at the National University of Singapore have developed a probe that provides doctors with clearer and more accurate magnetic resonance images of liver cancer.

The U.S. Food and Drug Administration (FDA) approved the use of Stivarga (regorafinib) for the treatment of patients with hepatocellular carcinoma (HCC), a form of…

Transplanting fecal bacteria from a healthy person to someone who has a liver-connected brain impairment may be an effective way to treat the condition, known…

Insulin resistance (IR) is associated with poorer cognitive performance and greater cognitive decline in heart disease patients with or without diabetes, a new study says. The…

A peptide called pNaKtide has shown promise in improving the clinical manifestations associated with non-alcoholic fatty liver disease (NAFLD) and atherosclerosis, according to researchers at Marshall…

Scientists have long believed that liver cancer cells needed fat molecules to survive, and that by blocking fat production, the cancer would starve. But a new Australian…

Drinking coffee may reduce the risk of chronic liver disease, especially in patients with other conditions affecting the liver, including non-alcoholic fatty liver disease, according…

Combining the chemotherapy agent Sutent (sunitinib) and immunotherapy may be a promising strategy to fight hepatocellular carcinoma, the most common type of liver cancer, according…

Patients with cirrhosis (liver damage) may be at a much lower risk of liver cancer than originally assumed, according to results of a recent study…